Publications
- Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase2007 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase2007 | Publication without faculty affiliation
- New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin2006 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase2005 | Faculty of Pharmacy in Hradec Králové, Central Library of Charles University
- Synthesis of the novel series of bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterasePublication without faculty affiliation
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | First Faculty of Medicine
- Recent advances in dopamine D-2 receptor ligands in the treatment of neuropsychiatric disorders2023 | Publication without faculty affiliation
- Strategies for enhanced bioavailability of oxime reactivators in the central nervous system2023 | Publication without faculty affiliation
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Central Library of Charles University
- Charged pyridinium oximes with thiocarboxamide moiety are equally or less effective reactivators of organophosphate-inhibited cholinesterases compared to analogous carboxamides2022 | Publication without faculty affiliation
Loading network view...